Previous studies have shown that ROS–SLC34A2 fusion genes could promote tumor cells proliferation in glioma and non‐small cell lung cancer 23, 24; this effect was regarded as being associated with the proliferation and invasion abilities of CSCs 13. This evidence concerns the gene SLC34A2 and central nervous system cancer.